Global X Russell 2000 Covered Call ETF RYLD
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Expense ratio
- 0.60%
- Net assets
- $1.4B
- Holdings
- 8
- 12-month distribution yield
- 12.30%
- Asset class
- Equity
Global X Russell 2000 Covered Call ETF (RYLD) is an exchange-traded fund listed on NYSE Arca in the United States, issued by Global X. Its category is Equity · US (equity). Its last price was US$15.19 on 20 Oct 2026. Its expense ratio is 0.6% a year, from its prospectus dated 1 Mar 2026. It reported net assets of US$1.37 billion as of 31 Jul 2026. Its latest holdings report lists 8 holdings as of 31 Jul 2026. Over the last 12 months it paid distributions of US$1.87 a unit, a 12-month distribution yield of 12.30%, paid monthly.
Fees
- Total annual operating expenses (gross)
- 0.60%
- Net, after fee waivers or reimbursements
- No waiver stated
- Management fee
- 0.60%
- Prospectus date
- 1 Mar 2026
- Filed with the SEC
- 26 Feb 2026
Size and reporting
- Net assets
- $1,371,304,124
- Total assets
- $1,386,214,101
- Holdings as of
- 31 Jul 2026
- Report made public
- 29 Sep 2026 (60 days after the month end)
Top holdings
Largest 8 of 8 positions, as of 31 Jul 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | Global X Russell 2000 ETF GLOBAL X RUSSELL 2000 ETF MUTUAL FUND | US37960A4537 | 100.94% | $1.4B | Equity (common) | United States | USD |
| 2 | RUT US 08/21/26 C2970 SHORT | No identifier reported | -1.04% | -$14.3M | Interest rate derivatives | United States | USD |
| 3 | INHIBRX INC CONTINGENT VALUE RIGHT | US45720L1070 | <0.01% | $10K | Equity (common) | United States | USD |
| 4 | NOVARTIS AG - CVR 1 SHARE OF 66987VCVR AND 40 USD PER KDNY | No identifier reported | <0.01% | $10K | Equity (common) | United States | USD |
| 5 | CARTESIAN THERAPEUTICS INC CONTINGENT VALUE RIGHT - RNAC US | US8162121128 | 0.00% | $0 | Equity (common) | United States | USD |
| 6 | OMNIAB INC - 12.5 EARNOUT COMMON STOCK | US68218J2024 | 0.00% | $0 | Equity (common) | United States | USD |
| 7 | OMNIAB INC - 15.00 EARNOUT COMMON STOCK | US68218J3014 | 0.00% | $0 | Equity (common) | United States | USD |
| 8 | RAIN ONCOLOGY INC RAIN ONCOLOGY INC CONTINGENT VALUE RIGHT - RAIN US | US750CVR0297 | 0.00% | $0 | Equity (common) | United States | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 100.94% | |
| Interest rate derivatives | -1.04% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 99.90% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 99.90% |
Sector
No sector data
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- $1.8680
- 12-month yield
- 12.30%
- Frequency
- Monthly
- Latest ex-date
- 19 Oct 2026
12-month yield = distributions per unit with an ex-date in the last 12 months ($1.8680) ÷ latest price ($15.19) × 100 = 12.30%. It looks back, so it is not a forecast; special distributions in the window are included.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (59 payments)
| Ex-date | Amount per unit |
|---|---|
| 19 Oct 2026 | $0.1480 |
| 21 Sep 2026 | $0.1480 |
| 24 Aug 2026 | $0.1650 |
| 20 Jul 2026 | $0.1610 |
| 22 Jun 2026 | $0.1620 |
| 18 May 2026 | $0.1570 |
| 20 Apr 2026 | $0.1570 |
| 23 Mar 2026 | $0.1480 |
| 23 Feb 2026 | $0.1580 |
| 20 Jan 2026 | $0.1570 |
| 22 Dec 2025 | $0.1550 |
| 24 Nov 2025 | $0.1520 |
| 20 Oct 2025 | $0.1530 |
| 22 Sep 2025 | $0.1520 |
| 18 Aug 2025 | $0.1510 |
| 21 Jul 2025 | $0.1500 |
| 23 Jun 2025 | $0.1490 |
| 19 May 2025 | $0.1480 |
| 21 Apr 2025 | $0.1430 |
| 24 Mar 2025 | $0.1540 |
| 24 Feb 2025 | $0.1630 |
| 21 Jan 2025 | $0.1680 |
| 30 Dec 2024 | $0.1660 |
| 18 Nov 2024 | $0.1660 |
| 21 Oct 2024 | $0.1660 |
| 23 Sep 2024 | $0.1620 |
| 19 Aug 2024 | $0.1610 |
| 22 Jul 2024 | $0.1610 |
| 24 Jun 2024 | $0.1610 |
| 20 May 2024 | $0.1650 |
| 22 Apr 2024 | $0.1630 |
| 18 Mar 2024 | $0.1670 |
| 20 Feb 2024 | $0.1630 |
| 22 Jan 2024 | $0.1650 |
| 28 Dec 2023 | $0.1670 |
| 20 Nov 2023 | $0.1680 |
| 23 Oct 2023 | $0.1620 |
| 18 Sep 2023 | $0.1730 |
| 21 Aug 2023 | $0.1740 |
| 24 Jul 2023 | $0.1800 |
| 20 Jun 2023 | $0.1830 |
| 22 May 2023 | $0.1610 |
| 24 Apr 2023 | $0.1820 |
| 21 Feb 2023 | $0.1960 |
| 23 Jan 2023 | $0.1960 |
| 29 Dec 2022 | $0.1870 |
| 21 Nov 2022 | $0.1990 |
| 24 Oct 2022 | $0.1950 |
| 19 Sep 2022 | $0.1960 |
| 22 Aug 2022 | $0.2070 |
| 18 Jul 2022 | $0.2120 |
| 21 Jun 2022 | $0.2020 |
| 23 May 2022 | $0.2110 |
| 18 Apr 2022 | $0.2350 |
| 21 Mar 2022 | $0.2400 |
| 22 Feb 2022 | $0.2320 |
| 24 Jan 2022 | $0.2230 |
| 30 Dec 2021 | $0.3070 |
| 22 Nov 2021 | $0.2550 |
Filings and sources
- Form N-PORT report for July 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000065001) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- RYLD and VTI Vanguard Morningstar Total Stock Market ETF
- RYLD and VOO Vanguard S&P 500 ETF
- RYLD and IVV iShares Core S&P 500 ETF
- RYLD and QQQ Invesco QQQ Trust, Series 1